Literature DB >> 10548638

A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage.

S A Brigham1, C Conlon, R G Farquharson.   

Abstract

Recurrent miscarriage is a difficult clinical problem occurring in approximately 1-2% of fertile women. Following investigation, most cases fail to reveal an identifiable cause and are therefore classified as idiopathic. The aim of this study was to identify important gestational milestones for pregnancy success prediction in women following idiopathic recurrent miscarriage. A total of 325 consecutive patients with idiopathic recurrent miscarriage was involved in a prospective longitudinal observational study. Patients were identified from a miscarriage database of 716 patients. Preconceptual presentation and investigation excluded patients from the study sample with known associations of recurrent pregnancy loss, such as antiphosholipid syndrome, oligomenorrhoea, mid-trimester loss and other rare causes, e.g. abnormal parental karyotype. Following early presentation in a subsequent pregnancy, all patients followed a standard clinic protocol including fetal viability ultrasonography on a fortnightly basis throughout the first trimester. Kaplan-Meier curves were constructed for pregnancy outcome. Out of 325 idiopathic cases, 70% (n = 226) conceived, with a 75% success rate. Of 55 miscarriages, longitudinal assessment showed that six losses occurred following detection of fetal cardiac activity (3%). Data from this large study group have enabled accurate prediction of future pregnancy success and have established important gestational milestones for women with idiopathic recurrent miscarriage.

Entities:  

Mesh:

Year:  1999        PMID: 10548638     DOI: 10.1093/humrep/14.11.2868

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  37 in total

1.  Investigation of recurrent miscarriages.

Authors:  Fred Kavalier
Journal:  BMJ       Date:  2005-07-16

Review 2.  Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.

Authors:  Paulien G de Jong; Stef Kaandorp; Marcello Di Nisio; Mariëtte Goddijn; Saskia Middeldorp
Journal:  Cochrane Database Syst Rev       Date:  2014-07-04

3.  Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial.

Authors:  Elisabeth Pasquier; Luc de Saint Martin; Caroline Bohec; Céline Chauleur; Florence Bretelle; Gisèle Marhic; Grégoire Le Gal; Véronique Debarge; Frédéric Lecomte; Christine Denoual-Ziad; Véronique Lejeune-Saada; Serge Douvier; Michel Heisert; Dominique Mottier
Journal:  Blood       Date:  2015-01-30       Impact factor: 22.113

4.  Karyotype evaluation of repeated abortions in primary and secondary recurrent pregnancy loss.

Authors:  T V Nikitina; E A Sazhenova; D I Zhigalina; E N Tolmacheva; N N Sukhanova; I N Lebedev
Journal:  J Assist Reprod Genet       Date:  2020-02-03       Impact factor: 3.412

5.  Methylenetetrahydrofolate Reductase C677T Polymorphism and Recurrent Pregnancy Loss Risk in Asian Population: A Meta-analysis.

Authors:  Vandana Rai
Journal:  Indian J Clin Biochem       Date:  2016-02-06

6.  Acupuncture as a therapeutic treatment option for threatened miscarriage.

Authors:  Debra Betts; Caroline A Smith; Dahlen G Hannah
Journal:  BMC Complement Altern Med       Date:  2012-03-22       Impact factor: 3.659

Review 7.  Recurrent miscarriage.

Authors:  Kirsten Duckitt; Aysha Qureshi
Journal:  BMJ Clin Evid       Date:  2011-02-01

Review 8.  The Importance of an Evidence-based Workup for Recurrent Pregnancy Loss.

Authors:  Karen J Gibbins; T Flint Porter
Journal:  Clin Obstet Gynecol       Date:  2016-09       Impact factor: 2.190

Review 9.  Recurrent miscarriage.

Authors:  Kirsten Duckitt; Aysha Qureshi
Journal:  BMJ Clin Evid       Date:  2008-04-14

Review 10.  Chinese herbal medicines for unexplained recurrent miscarriage.

Authors:  Lu Li; Lixia Dou; Ping Chung Leung; Tony Kwok Hung Chung; Chi Chiu Wang
Journal:  Cochrane Database Syst Rev       Date:  2016-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.